Literature DB >> 19289027

Optimal management of acute aortic dissection.

Venu Menon1, Jay Sengupta, Samuel Unzek.   

Abstract

Acute aortic syndrome (AAS) encompasses a group of life-threatening aortic disorders that are increasing in prevalence. It classically presents with abrupt-onset chest pain that is of maximum intensity at onset. The syndrome requires prompt recognition and efficient treatment to optimize outcome. Contrast-enhanced CT is most commonly used as the definitive diagnostic imaging modality. Patients must be expeditiously transferred to institutions with case experience and medical, surgical, and endovascular expertise. Stanford type A dissections involve the ascending aorta and require emergent surgical consideration, unless underlying comorbidities make surgical risk prohibitive. Patients with Stanford type B, or descending, aortic dissection are less prone to rupture, shock, and cardiac complications. These patients are initially medically managed with targeted blood pressure and heart rate control. Surgical management is reserved for patients with intractable or recurrent pain, aortic expansion, end-organ ischemia, or progression of dissection. The feasibility of endovascular treatment is established, and its role in management continues to expand. Long-term follow-up with medical treatment and serial imaging of AAS patients is critical. Future directions in the diagnosis and treatment of AAS include using biomarkers to aid in diagnosis and prognosis, enhanced imaging with better resolution and reduced radiation exposure, and definition of the role of endovascular methods in acute and chronic settings.

Entities:  

Year:  2009        PMID: 19289027     DOI: 10.1007/s11936-009-0015-7

Source DB:  PubMed          Journal:  Curr Treat Options Cardiovasc Med        ISSN: 1092-8464


  40 in total

1.  Endovascular stent-graft placement for the treatment of acute aortic dissection.

Authors:  M D Dake; N Kato; R S Mitchell; C P Semba; M K Razavi; T Shimono; T Hirano; K Takeda; I Yada; D C Miller
Journal:  N Engl J Med       Date:  1999-05-20       Impact factor: 91.245

2.  Large area of the false lumen favors secondary dilatation of the aorta after acute type A aortic dissection.

Authors:  Franz F Immer; Eva Krähenbühl; Urs Hagen; Mario Stalder; Pascal A Berdat; Friedrich S Eckstein; Jürg Schmidli; Thierry P Carrel
Journal:  Circulation       Date:  2005-08-30       Impact factor: 29.690

3.  Role and results of surgery in acute type B aortic dissection: insights from the International Registry of Acute Aortic Dissection (IRAD).

Authors:  Santi Trimarchi; Christoph A Nienaber; Vincenzo Rampoldi; Truls Myrmel; Toru Suzuki; Eduardo Bossone; Valerio Tolva; Michael G Deeb; Gilbert R Upchurch; Jeanna V Cooper; Jianming Fang; Eric M Isselbacher; Thoralf M Sundt; Kim A Eagle
Journal:  Circulation       Date:  2006-07-04       Impact factor: 29.690

4.  64 slice cardiovascular CT in the emergency department: concepts and first experiences.

Authors:  G Savino; C Herzog; P Costello; U J Schoepf
Journal:  Radiol Med       Date:  2006-05-29       Impact factor: 3.469

Review 5.  Aortic dissections and dissecting aneurysms.

Authors:  C E Anagnostopoulos; M J Prabhakar; C F Kittle
Journal:  Am J Cardiol       Date:  1972-08       Impact factor: 2.778

6.  The diagnosis of thoracic aortic dissection by noninvasive imaging procedures.

Authors:  C A Nienaber; Y von Kodolitsch; V Nicolas; V Siglow; A Piepho; C Brockhoff; D H Koschyk; R P Spielmann
Journal:  N Engl J Med       Date:  1993-01-07       Impact factor: 91.245

7.  Endovascular treatment of thoracic aortic aneurysms: results of the phase II multicenter trial of the GORE TAG thoracic endoprosthesis.

Authors:  Michel S Makaroun; Ellen D Dillavou; Stephen T Kee; Gregorio Sicard; Elliot Chaikof; Joseph Bavaria; David Williams; Richard P Cambria; R Scott Mitchell
Journal:  J Vasc Surg       Date:  2005-01       Impact factor: 4.268

8.  Angiotensin II blockade and aortic-root dilation in Marfan's syndrome.

Authors:  Benjamin S Brooke; Jennifer P Habashi; Daniel P Judge; Nishant Patel; Bart Loeys; Harry C Dietz
Journal:  N Engl J Med       Date:  2008-06-26       Impact factor: 91.245

9.  Recombinant activated factor VII for refractory bleeding after acute aortic dissection surgery: a propensity score analysis.

Authors:  Luigi Tritapepe; Vincenzo De Santis; Domenico Vitale; Cecilia Nencini; Fabio Pellegrini; Giovanni Landoni; Federico Toscano; Fabio Miraldi; Paolo Pietropaoli
Journal:  Crit Care Med       Date:  2007-07       Impact factor: 7.598

10.  Expert consensus document on the treatment of descending thoracic aortic disease using endovascular stent-grafts.

Authors:  Lars G Svensson; Nicholas T Kouchoukos; D Craig Miller; Joseph E Bavaria; Joseph S Coselli; Michael A Curi; Holger Eggebrecht; John A Elefteriades; Raimund Erbel; Thomas G Gleason; Bruce W Lytle; R Scott Mitchell; Christoph A Nienaber; Eric E Roselli; Hazim J Safi; Richard J Shemin; Gregorio A Sicard; Thoralf M Sundt; Wilson Y Szeto; Grayson H Wheatley
Journal:  Ann Thorac Surg       Date:  2008-01       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.